Patheon Softgels Inc.

Banner Life Sciences LLC

Banner Lifie Sciences LLC

Chue Yang

Tatyana Dyakonov

Saujanya L Gosangari

Aqeel A Fatmi

Justin R Hughey

YinYan Zhao

Yunhua Hu

Martin Piest

Henricus Marinus Gerardus Maria Van Duijnhoven

Mervin Williams, Jr

Shingai Majuru

Jason M Vaughn

George Vamvakas

Derek Bush

Nashwa El-Gendy

Yinyan Zhao

Saujanya Gosangari

Mervin Williams

Henricus Marinus Van Duijnhoven

Described herein are oral pharmaceutical compositions suitable for chewing, sucking, or buccal dissolution comprising soft gel capsules and liquid fills, methods for making the same, and methods for treating subjects in need thereof with such capsules. In particular, oral pharmaceutical compositions comprising chewable, suckable, or dissolvable soft gel capsules with various flowable fill compositions are described.

Liquisoft capsules

Described herein are oral abuse deterrent pharmaceutical compositions, methods for making the same, and methods for treating pain by administering the pharmaceutical composition to a subject in need thereof. In particular, an oral abuse deterrent pharmaceutical composition comprising a soft capsule and a controlled release matrix comprising oxycodone are described.

Abuse deterrent dosage forms

Described herein are controlled release oral pharmaceutical compositions and methods for making the same. These pharmaceutical compositions provide a non-burst release of one or more active pharmaceutical ingredients. In particular, a non-burst controlled release oral pharmaceutical composition comprising a capsule and an abuse deterrent controlled release matrix comprising one or more active pharmaceutical ingredients are described.

Non-burst releasing pharmaceutical composition

Described herein are controlled release oral pharmaceutical compositions for delivering active pharmaceutical ingredients to the colon and methods for making the same. In particular, an oral pharmaceutical composition comprising a soft capsule and a controlled release matrix for delivering active pharmaceutical ingredients to the colon are described.

Compositions for colonic delivery of drugs

A hard or soft capsule is disclosed comprising a shell and a fill material, wherein the shell comprises an interpenetrating network comprising a silk polymer and a film-forming natural polymer. A method of making a hard or soft capsule is also disclosed, comprising dissolving a silk protein in a solvent system to form a solubilized silk protein solution; mixing the solubilized silk protein solution with a film-forming natural polymer to form a homogenous shell material; and encapsulating a fill material with the homogenous shell material.

Silk-based capsules

Opioid abuse deterrent dosage forms

Described herein are abuse deterrent oral pharmaceutical compositions, methods for making the same, and methods of treatment using such compositions. In particular, oral pharmaceutical compositions that mitigate the risk of overingestion of one or more active pharmaceutical ingredients are described.

Anti-overingestion dosage forms

Growing community of inventors

Greensboro, NC, United States of America

Chue Yang